Related by context. Frequent words. (Click for all words.) 58 multicentre 58 Phase 2b study 57 Phase IIa trial 56 Phase 1b clinical 56 dose escalation trial 56 Phase 2a trial 56 TORISEL 56 azacitidine 56 multicenter 55 phase IIa 55 Phase 2b trial 54 RG# [001] 54 diabetic neuropathic pain 54 dose escalation study 54 evaluable patients 54 Phase 2a 54 Phase 2a clinical 54 PROMACTA 54 Phase IIb clinical 53 vandetanib 53 phase IIb 53 Phase Ib 53 blind randomized 53 multicenter study 53 metastatic renal cell carcinoma 53 COPAXONE R 53 dose escalation 53 multicenter clinical 53 Phase 1b 53 substudy 53 bosentan 53 topotecan 53 sunitinib 53 ofatumumab 52 myelodysplastic syndromes MDS 52 randomized Phase 52 Phase IIa clinical 52 imetelstat 52 etoposide 52 biologic therapy 52 peginterferon alfa 2a 52 peginterferon alfa 2b 52 mcg kg 52 temozolomide 52 evaluable 52 randomized placebo controlled 52 mitoxantrone 52 RECIST criteria 52 chemoradiation 52 tamibarotene 51 vinorelbine 51 vicriviroc 51 mg BID 51 SEROQUEL 51 phase 2a 51 interferon alfa 51 blinded placebo controlled 51 EORTC 51 label dose escalation 51 randomized 51 pivotal Phase III 51 prospective randomized 51 PF # [001] 51 sitagliptin 51 monotherapy 51 aripiprazole 51 cytarabine 51 multicenter randomized double 51 HCV infected 51 Phase III pivotal 51 Torisel 51 blind randomized placebo 51 Phase 2b 51 ZYBRESTAT 51 placebo controlled trials 51 LIALDA 50 Phase 2b clinical 50 randomized controlled 50 zoledronic acid 50 cetrorelix 50 sorafenib 50 diagnosed multiple myeloma 50 HGS ETR1 50 certolizumab pegol 50 Taxotere ® 50 decitabine 50 insulin glargine 50 placebo controlled 50 sustained virologic response 50 tiotropium 50 pharmacodynamics 50 lacosamide 50 randomized controlled clinical 50 median PFS 50 free survival PFS 50 mixed dyslipidemia 50 elagolix 50 chronic lymphocytic leukemia CLL 50 Phase IIb 50 fluorouracil 50 lubiprostone